News Release - July 20, 2007

Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS

Source: Abbott

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.